169 related articles for article (PubMed ID: 24477403)
21. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF
Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103
[TBL] [Abstract][Full Text] [Related]
22. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.
Roy LD; Sahraei M; Schettini JL; Gruber HE; Besmer DM; Mukherjee P
BMC Cancer; 2014 Mar; 14():225. PubMed ID: 24674692
[TBL] [Abstract][Full Text] [Related]
23. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
[TBL] [Abstract][Full Text] [Related]
24. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin expression and the effect of anti-VLA-4 mAb treatment in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Pyka-Fościak G; Litwin JA; Lis GJ
Folia Neuropathol; 2023; 61(2):129-137. PubMed ID: 37587887
[TBL] [Abstract][Full Text] [Related]
26. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.
Peled A; Kollet O; Ponomaryov T; Petit I; Franitza S; Grabovsky V; Slav MM; Nagler A; Lider O; Alon R; Zipori D; Lapidot T
Blood; 2000 Jun; 95(11):3289-96. PubMed ID: 10828007
[TBL] [Abstract][Full Text] [Related]
27. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
Breuer J; Korpos E; Hannocks MJ; Schneider-Hohendorf T; Song J; Zondler L; Herich S; Flanagan K; Korn T; Zarbock A; Kuhlmann T; Sorokin L; Wiendl H; Schwab N
J Neuroinflammation; 2018 Aug; 15(1):236. PubMed ID: 30134924
[TBL] [Abstract][Full Text] [Related]
28. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
29. Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
Tsunoda I; Terry EJ; Marble BJ; Lazarides E; Woods C; Fujinami RS
Brain Pathol; 2007 Jan; 17(1):45-55. PubMed ID: 17493037
[TBL] [Abstract][Full Text] [Related]
30. The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter.
Banisadr G; Frederick TJ; Freitag C; Ren D; Jung H; Miller SD; Miller RJ
Neurobiol Dis; 2011 Oct; 44(1):19-27. PubMed ID: 21684336
[TBL] [Abstract][Full Text] [Related]
31. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
Theien BE; Vanderlugt CL; Nickerson-Nutter C; Cornebise M; Scott DM; Perper SJ; Whalley ET; Miller SD
Blood; 2003 Dec; 102(13):4464-71. PubMed ID: 12933585
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
[TBL] [Abstract][Full Text] [Related]
34. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
35. CXC chemokine receptors expression during chronic relapsing experimental autoimmune encephalomyelitis.
Glabinski AR; O'Bryant S; Selmaj K; Ransohoff RM
Ann N Y Acad Sci; 2000; 917():135-44. PubMed ID: 11268337
[TBL] [Abstract][Full Text] [Related]
36. Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment.
Deloire MS; Touil T; Brochet B; Dousset V; Caillé JM; Petry KG
Mult Scler; 2004 Oct; 10(5):540-8. PubMed ID: 15471371
[TBL] [Abstract][Full Text] [Related]
37. CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.
Wilson GC; Freeman CM; Kuethe JW; Quillin RC; Nojima H; Schuster R; Blanchard J; Edwards MJ; Caldwell CC; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(8):G702-9. PubMed ID: 25721302
[TBL] [Abstract][Full Text] [Related]
38. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory macrophage migration in experimental autoimmune encephalomyelitis.
Karpus WJ
Methods Mol Biol; 2013; 1013():161-9. PubMed ID: 23625498
[TBL] [Abstract][Full Text] [Related]
40. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
Mousavi A
Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
